Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mayne Pharma Group Ltd Announces Acquisition Of Libertas


Monday, 1 Jul 2013 06:44pm EDT 

Mayne Pharma Group Ltd announced that it has acquired US-based Libertas Pharma Inc. (Libertas). Libertas is a generic pharmaceutical company headquartered in Atlanta, Georgia that distributes and markets a range of niche products in the US. Libertas is highly complementary to the Metrics Products division having six marketed ANDA products and two pipeline ANDAs distributed through the same retail pharmacy channel with no product overlap. The terms of the acquisition were not disclosed. 

Company Quote

0.7525
0.0030 +0.33%
16 Sep 2014